FDA gives fast-track status to Pfizer and Arvinas' breast cancer drug 08-Feb-2024 By Liza Laws A small molecule oral treatment for breast cancer has been granted fast-track designation by the US Food and Drug Administration (FDA).
STA Pharma completes clinical supply of PhoenixMD’s breast cancer treatment 10-Jun-2019 By Maggie Lynch Clinical trial supply for the first targeted treatment of triple-negative breast cancer completed through PhoenixMD and STA Pharmaceutical agreement.
US FDA approves Pfizer’s PARP inhibitor for metastatic breast cancer 23-Oct-2018 By Maggie Lynch The FDA approved Pfizer’s therapy for metastatic breast cancers, after clinical trials showed strong progression-free survival rates.